551923-14-9 Usage
General Description
The chemical "4-(3-methyl-piperidin-1-yl)-piperidine" is a heterocyclic compound that belongs to the class of piperidine derivatives. It has a molecular formula of C11H22N2 and a molecular weight of 182.3 g/mol. 4-(3-METHYL-PIPERIDIN-1-YL)-PIPERIDINE is commonly used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. It is known for its potential biological activities and has been investigated for its antiviral, anti-inflammatory, and analgesic properties. Additionally, it has also been studied for its potential use in the treatment of neurological disorders and as a chiral auxiliary in asymmetric synthesis. Overall, "4-(3-methyl-piperidin-1-yl)-piperidine" has shown to be a versatile compound with various potential applications in the fields of medicine and agriculture.
Check Digit Verification of cas no
The CAS Registry Mumber 551923-14-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,1,9,2 and 3 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 551923-14:
(8*5)+(7*5)+(6*1)+(5*9)+(4*2)+(3*3)+(2*1)+(1*4)=149
149 % 10 = 9
So 551923-14-9 is a valid CAS Registry Number.
551923-14-9Relevant articles and documents
SUBSTITUTED BIPIPERIDINYL DERIVATIVES
-
Paragraph 0770; 0771; 0772, (2016/11/17)
The invention relates to novel substituted bipiperidinyl derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of diabetic microangiopathies, diabetic ulcers on the extremities, in particular for promoting wound healing of diabetic foot ulcers, diabetic heart failure, diabetic coronary microvascular heart disorders, peripheral and cardiac vascular disorders, thromboembolic disorders and ischaemias, peripheral circulatory disturbances, Raynaud's phenomenon, CREST syndrome, microcirculatory disturbances, intermittent claudication, and peripheral and autonomous neuropathies.